Lulu Xie Selected Research

Lulu Xie Research Topics

11	Neoplasms (Cancer) 01/2024 - 05/2016
6	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2019
2	Communicable Diseases (Infectious Diseases) 02/2023 - 05/2019
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
2	Infections 01/2023 - 05/2019
2	Constipation 01/2022 - 12/2021
2	Starvation 03/2021 - 08/2018
2	Hepatoblastoma 01/2021 - 12/2020
1	Heart Diseases (Heart Disease) 07/2023
1	Hypertension (High Blood Pressure) 07/2023
1	Lung Diseases (Lung Disease) 07/2023
1	Liver Failure 07/2023
1	Renal Insufficiency (Renal Failure) 07/2023
1	Asthma (Bronchial Asthma) 02/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Dementia (Dementias) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Nausea 12/2022
1	Cancer Pain 12/2022
1	Fatigue 12/2022
1	Vomiting 12/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2022
1	Cholangiocarcinoma 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2021
1	Neuroblastoma 10/2020
1	Carcinogenesis 10/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Pneumonia (Pneumonitis) 05/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2017
1	Mouth Neoplasms (Oral Cancer) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Stroke (Strokes) 01/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016
1	Ischemic Stroke 01/2016
1	Cognitive Dysfunction 12/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2014

3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
3	Small Interfering RNA (siRNA)IBA 10/2019 - 01/2017
2	lenvatinibIBA 01/2024 - 01/2022
2	CytokinesIBA 11/2023 - 01/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 05/2019
2	RNA (Ribonucleic Acid)IBA 10/2020 - 08/2018
1	sintilimabIBA 01/2024
1	AntigensIBA 11/2023
1	regorafenibIBA 03/2023
1	Amoxicillin (Wymox)FDA LinkGeneric 02/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2023
1	pirfenidoneIBA 01/2023
1	Hyaluronan ReceptorsIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Syk KinaseIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	CytokininsIBA 03/2021
1	Indoleacetic Acids (Auxin)IBA 03/2021
1	Sucrose (Saccharose)IBA 03/2021
1	Long Noncoding RNAIBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2020
1	Ligases (Synthetase)IBA 12/2020
1	UbiquitinIBA 12/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2020
1	HesperidinIBA 01/2020
1	CateninsIBA 01/2019
1	secalonic acidIBA 01/2019
1	MycotoxinsIBA 01/2019
1	Syntex adjuvant formulationIBA 01/2019
1	pirarubicinIBA 01/2019
1	Phosphates (Orthophosphate)IBA 08/2018
1	SurvivinIBA 01/2017
1	Beclin-1IBA 01/2017
1	Contrast MediaIBA 05/2016
1	Fetal Proteins (Fetoprotein)IBA 05/2016
1	Isoflurane FDA LinkGeneric 01/2016
1	Neuroprotective AgentsIBA 01/2016
1	Anesthetics (Anesthetic Agents)IBA 01/2016
1	Protein AggregatesIBA 12/2014

3	Therapeutics 01/2023 - 01/2022
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024
1	Radiofrequency Ablation 11/2023
1	Length of Stay 07/2023
1	Artificial Respiration (Mechanical Ventilation) 07/2023
1	Immunotherapy 01/2023
1	Cataract Extraction 01/2023
1	Radiotherapy 01/2023
1	Fecal Microbiota Transplantation 12/2021
1	Noninvasive Ventilation 01/2020
1	Sutures (Suture) 01/2016
1	Anesthesia 01/2016